Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sino Biopharmaceutical
Pharma
Akeso’s Anniko enters crowded US PD-1 market
The FDA approval puts Akeso's Anniko in direct competition with Coherus and Junshi's fellow China-made PD-1 Loqtorzi in nasopharyngeal carcinoma.
Angus Liu
Apr 25, 2025 10:55am
Geopolitical tensions, Carvykti, Enhertu—Fierce Pharma Asia
Apr 12, 2024 8:20am
Leqembi, Enhertu and Cipla—Fierce Pharma Asia
Mar 10, 2023 8:10am
Carvykti, Sanofi, BeiGene—Fierce Pharma Asia
Feb 3, 2023 8:25am
Biocon, AstraZeneca, Shionogi—Fierce Pharma Asia
Jun 24, 2022 9:10am
Novartis, BMS, Innovent, Lilly, Akebia await FDA decisions
Mar 2, 2022 10:10am
